# An experimental treatment improves the cognitive ability and gut microbiota of mice with fragile X syndrome

Source: [Medical Xpress - latest medical and health news stories](https://medicalxpress.com/news/2026-11-experimental-treatment-cognitive-ability-gut.html) · 2026-11-19 · Medicine
Page: https://themorning.science/story/an-experimental-treatment-improves-the-cognitive-ability-and-gut-microbiota-of-m-78841bb37253ebd1
Kind: research · Impact: low

## In brief

- Ongoing treatment with a drug that inhibits the endocannabinoid system peripherally improved memory deficits in fragile X syndrome mouse models.
- The treatment also reduced synaptic alterations, mitigated gut microbiota dysbiosis and restored intestinal barrier integrity markers.
- The treatment is experimental and the findings come from mice.

## Why it matters

The results point to the peripheral endocannabinoid system and the gut as possible targets in fragile X syndrome research, though the evidence so far comes only from mouse models.

## Coverage

- [An experimental treatment improves the cognitive ability and gut microbiota of mice with fragile X syndrome](https://medicalxpress.com/news/2026-11-experimental-treatment-cognitive-ability-gut.html) — Medical Xpress - latest medical and health news stories, 2026-11-19

Tags: fragile x syndrome, endocannabinoid system, gut microbiota, memory, mouse models

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
